Tulevik | Life Sciences Deal Intelligence & M&A Advisory
Curated M&A advisory is Tulevik’s transaction execution service for buyers and sellers of life sciences manufacturing and services assets. Engagements are led by the firm’s principals rather than delegated to a junior team, and cover buy-side and sell-side processes, carve-outs and divestitures, sale readiness, and buyer or investor outreach — supported by analysts and specialists selected for the mandate.
In most advisory firms the senior people who win the mandate are not the people who execute it. The pitch team hands over to an associate team, and the client discovers the substitution after signing.
On a manufacturing transaction that substitution costs more than usual. The questions that decide whether a deal works are technical — what the facility can actually run, at what capacity, what the quality record implies about remediation cost — and a generalist associate does not know to ask them.
Tulevik is structured so the substitution cannot happen. A principal runs the mandate from first conversation to close, with analysts and specialists brought in around them for the specific work.
Where the target is not yet identified, Deal intelligence comes first. Where the question is which market to enter, Insight-driven market entry is the starting point.